Drug Type Small molecule drug |
Synonyms BLX-0200 |
Target |
Action modulators |
Mechanism HDAC6 modulators(Histone deacetylase 6 modulators) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Discovery | United States | 29 Sep 2022 | |
Amyotrophic Lateral Sclerosis 11 | Discovery | United States | 29 Sep 2022 |